Manipal Health Enterprises Limited
PROSPECTUS · filed 03 Aug 2026
Manipal Health Enterprises is a healthcare provider that primarily generates revenue from inpatient care in specialized medical fields such as cardiac sciences and oncology. The company is raising Rs 8,000 crore through a fresh issue with no offer for sale component. Financially, the company has a debt-to-equity ratio of 1.2 and a return on equity of 10.57%. A high concentration of operations in Karnataka poses a significant risk, as does the reliance on specific medical specialties for a majority of gross inpatient revenue.
Partial analysis — some sections could not be read from the document (found: capitalisation, litigation, objects, price_basis, promoters, related_party, risks).
What stands out
Risk factor. A substantial number of our hospitals are located in Karnataka. We derived 46.40%, 51.55%, and 59.98% of our revenue from operations in Fiscals 2026, 2025 and 2024, respectively, from our hospitals in Karnataka. Any loss of business or disruption in the operations of these hospitals or geopolitical
Risk factor. We primarily generate revenue by providing inpatient care at our hospitals. Any inability to maintain or improve our admissions and hospital occupancy rates could adversely affect our business, financial condition, results of operations, cash flows and prospects. We are susceptible to risks of incon
Risk factor. We derived 64.30%, 62.56% and 61.55% of our gross inpatient revenue from cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics, and renal sciences (CONGO-R) specialties in Fiscals 2026, 2025 and 2024, respectively. Any negative changes in the demand for these specialties could adv
Primarily fresh capital. 100% of the offer is fresh issue, so most proceeds fund the company.
How the offer is structured
Fresh issue
₹8.00k Cr
New capital into the company
OFS share
0%
- Repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of our Material Subsidiaries, namely, Manipal Hospitals Private Limited₹5.55k Cr
- Acquisition of minority stake in our stepdown Subsidiary, Sahyadri Hospitals Private Limited₹574 Cr
- General corporate purposes₹1.63k Cr
Promoters, litigation & related parties
Promoter (pre)
69.9%
Risks the company discloses
A substantial number of our hospitals are located in Karnataka. We derived 46.40%, 51.55%, and 59.98% of our revenue from operations in Fiscals 2026, 2025 and 2024, respectively, from our hospitals in Karnataka. Any loss of business or disruption in the operations of these hospitals or geopolitical or policy changes in Karnataka could have a material adverse effect on our business, financial condition, results of operations, cash flows and prospects.(Geographic Concentration)
We primarily generate revenue by providing inpatient care at our hospitals. Any inability to maintain or improve our admissions and hospital occupancy rates could adversely affect our business, financial condition, results of operations, cash flows and prospects. We are susceptible to risks of inconsistent or declining patient volumes and/or hospital occupancy levels.(Operational Performance)
We derived 64.30%, 62.56% and 61.55% of our gross inpatient revenue from cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics, and renal sciences (CONGO-R) specialties in Fiscals 2026, 2025 and 2024, respectively. Any negative changes in the demand for these specialties could adversely impact our business, results of operations and financial condition.(Revenue Concentration)
A portion of the Net Proceeds is proposed to be utilized for repayment or prepayment of certain borrowings.(Use of Proceeds)
The ramp-up of new or expanded facilities may entail longer than expected lead times before achieving the targeted occupancy rates. Any failure by us to maintain or improve our admissions or occupancy rates may result in reduced profit margins, which may have an adverse impact on our business, financial condition, results of operations, cash flows and prospects.(Operational Performance)
Any significant slowdown in economic activities, social, political or economic disruption, sustained economic downturn or natural calamities or civil disruptions in Karnataka, or any changes in the policies of the state or local governments of this region or the Government of India, could disrupt our business operations, reduce the demand for our services, hamper the supply of medical supplies, require us to incur significant expenditure or change our business strategies.(Geographic Concentration)
Patient volumes and occupancy rates at our hospitals, and our ability to improve them, are affected by many factors within our control, such as our ability to attract and retain healthcare professionals, our ability to maintain and expand our specialty offerings and advanced equipment, our ability to price our offerings affordably, and our brand recognition.(Operational Performance)
Our reliance on these specialties (CONGO-R) may limit our ability to adapt to changing market conditions or diversify our service offerings, further exacerbating the potential impact of any adverse developments in these areas.(Revenue Concentration)